Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		249,567,000
Beginning balance at Dec. 31, 2022	$ 833,252	$ 25	$ 1,608,306	$ (7,599)	$ (767,480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		42,000
Issuance of common stock in connection with restricted stock units, net of tax	(69)		(69)
Stock-based compensation	13,882		13,882
Other comprehensive income (loss)	3,720			3,720
Net loss	(66,959)				(66,959)
Ending balance (in shares) at Mar. 31, 2023		249,609,000
Ending balance at Mar. 31, 2023	$ 783,826	$ 25	1,622,119	(3,879)	(834,439)
Beginning balance (in shares) at Dec. 31, 2023	253,957,709	253,958,000
Beginning balance at Dec. 31, 2023	$ 654,952	$ 25	1,657,133	(94)	(1,002,112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	868,826	869,000
Issuance of common stock upon exercise of stock options	$ 103		103
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		100,000
Issuance of common stock in connection with restricted stock units, net of tax	(76)		(76)
Stock-based compensation	9,155		9,155
Other comprehensive income (loss)	(310)			(310)
Net loss	$ (60,667)				(60,667)
Ending balance (in shares) at Mar. 31, 2024	254,926,880	254,927,000
Ending balance at Mar. 31, 2024	$ 603,157	$ 25	$ 1,666,315	$ (404)	$ (1,062,779)